Dr. Kurt Anderson

Dr. Karl Anderson sits in a lab at the University of Texas Medical Branch in Galveston on Wednesday, Nov. 27, 2019. Anderson managed clinical trials that have contributed to a FDA-approved breakthrough drug.

A University of Texas Medical Branch physician and his lab were instrumental in developing a new drug approved by the Federal Drug Administration last week, cited as “revolutionary” by patients and clinicians familiar with porphyria, a potentially deadly disease.

“I am still rejoicing over this revolutionary new treatment,” said Desiree Lyon of Houston, global director of the American Porphyria Foundation and a former patient of Dr. Karl Anderson at the medical branch.

Kathryn Eastburn: 409-683-5257; kathryn.eastburn@galvnews.com.

Recommended for you

(1) comment

Ernest Murrie

What great news. My daughter suffered with acute intermittent porphyria and was a patient of Dr. Anderson some years ago. Congratulations to him on this break through.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Thank you for Reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.